Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 18,000 shares at $18.58 ($334K) on 2023-06-14, disclosed to the SEC on 2023-06-16.
Scheduled sale ($334k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.58 | 9,000 | $167K | 50.0% |
| 2 | $18.58 | 9,000 | $167K | 50.0% |
| Total | $18.58 avg | 18,000 | $334K | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |